A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being

2021 ◽  
pp. 108468
Author(s):  
Nina A. Cooperman ◽  
Adam W. Hanley ◽  
Anna Kline ◽  
Eric L. Garland
Keyword(s):  
Clinical Trial ◽  
Chronic Pain ◽  
Drug Use ◽  
Randomized Clinical Trial ◽  
Illicit Drug ◽  
Methadone Treatment ◽  
Well Being ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Health And Well Being

scholarly journals A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use

2019 ◽  
Vol 97 ◽  
pp. 68-74
Author(s):  
Brent A. Moore ◽  
Frank D. Buono ◽  
Daniel P. Lloyd ◽  
Destiny M.B. Printz ◽  
David A. Fiellin ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Drug Use ◽  
Randomized Clinical Trial ◽  
Illicit Drug ◽  
Methadone Treatment ◽  
Illicit Drug Use

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial

Addiction ◽  
2018 ◽  
Vol 113 (7) ◽  
pp. 1264-1273 ◽  
Author(s):  
Nick Bansback ◽  
Daphne Guh ◽  
Eugenia Oviedo-Joekes ◽  
Suzanne Brissette ◽  
Scott Harrison ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Cost Effectiveness ◽  
Randomized Clinical Trial ◽  
Opioid Use Disorder ◽  
Opioid Use

Motivations for Diverted Buprenorphine Use in a Multisite Qualitative Study

2020 ◽  
Vol 50 (4) ◽  
pp. 550-565 ◽  
Author(s):  
Philip R. Kavanaugh ◽  
Katherine McLean
Keyword(s):  
Drug Use ◽  
Qualitative Study ◽  
Illicit Drug ◽  
Opioid Use Disorder ◽  
Drug Control ◽  
Risk Minimization ◽  
Opioid Use ◽  
Heroin Use ◽  
Site Variation ◽  
Treatment Policies

Drawing on a multisite sample of 40 persons who sell, share, or use diverted buprenorphine to manage opioid use disorder, in this study we describe why individuals seek to obtain buprenorphine outside of formal treatment contexts, and between-site variation regarding their motives and means. Findings indicate that both the provision and purchase of diverted buprenorphine support user-defined risk minimization strategies to avoid withdrawal, reduce heroin use, and satiate opioid cravings in periods of lowered tolerance. We also found that a subset of the sample used buprenorphine recreationally, and that it functioned to extend or augment illicit drug use careers. Implications of the findings are discussed in light of federal and state drug control and treatment policies.

scholarly journals Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended‐Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens

2020 ◽  
Vol 29 (4) ◽  
pp. 313-322 ◽  
Author(s):  
Sandra D. Comer ◽  
Paolo Mannelli ◽  
Danesh Alam ◽  
Antoine Douaihy ◽  
Narinder Nangia ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Extended Release ◽  
Opioid Use Disorder ◽  
Opioid Use

Non-Opioid Alternatives to Managing Chronic Pain

2019 ◽  
pp. 55-64
Author(s):  
Vanila Singh ◽  
Rachel Katonak
Keyword(s):  
Public Health ◽  
Chronic Pain ◽  
Criminal Behavior ◽  
Pain Treatment ◽  
Well Being ◽  
Evidence Base ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Prescription Drug Monitoring Programs ◽  
Pain Patients

While public health practitioners generally focus on the primary prevention of illness and disease by developing programs and policies that promote health and well-being, an understanding of chronic pain and its treatment is important for public health professionals working to address the opioid crisis. There are unintended consequences of well-intentioned policies that may restrict prescribing behavior or otherwise interrupt or change access to opioids. For example, one consequence of expanding state prescription drug monitoring programs has been concern by providers that “legitimate” pain patients may be subjected to increased suspicion and stigma and not able to obtain needed medications. State and federal efforts to shut down “pill mills” are vital to addressing diversion and criminal behavior, but pain patients who are also seen in these clinics may have an interruption in their treatment or access to medication. Understanding chronic pain treatment and non-opioid alternatives to pain management is an important part of developing sound public health policies to prevent opioid use disorder and its sequelae. This chapter presents these alternatives and the evidence base for each.

Sign in / Sign up

Export Citation Format

Share Document